Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-11-055024
Filing Date
2011-05-27
Accepted
2011-05-27 16:28:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 w82493b3e424b3.htm 424B3 855314
2 GRAPHIC w82493b3w8249300.gif GRAPHIC 5069
3 GRAPHIC w82493b3w8249302.jpg GRAPHIC 144086
  Complete submission text file 0000950123-11-055024.txt   1062224
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-171982 | Film No.: 11878609
SIC: 2834 Pharmaceutical Preparations